Insights That Power
Better Prescribing

BoomRx addresses one of clinics’ biggest operational frustrations, vendor silence, by making proactive, transparent communication a core part of its prescription fulfillment infrastructure, helping practices prevent disruptions, plan confidently, and protect the patient experience

BoomRx has launched an injection-free oral liquid testosterone therapy using nanoemulsion delivery, designed to help telemedicine, med spas, and hybrid practices expand TRT services without the operational burden of in-office injections.

BoomRx has launched a new oral liquid erectile dysfunction therapy that combines sildenafil, tadalafil, and vardenafil in a nanoemulsion delivery system, giving healthcare providers a more flexible, injection-free option to support men’s sexual health as part of comprehensive wellness care.

Short-term prescription spikes are manageable, but sustained demand exposes whether a clinic’s sourcing, fulfillment, and operational infrastructure is truly built to scale or destined to break under pressure.

BoomRx today announced the availability of oral semaglutide and tirzepatide options using advanced nanoemulsion delivery for medical clinics, med spas, wellness practices, and telemedicine providers nationwide.

In 2026, the question is no longer whether unified platforms will replace fragmented vendors. The question is how long clinics can afford to operate without one.

A Tampa-based pharmaceutical technology platform is aiming to fix one of the most persistent challenges for medical clinics, med spas and telehealth providers: pharmacy fulfillment.

BoomRX’s platform includes real-time order tracking, automated SMS delivery updates for patients and centralized reporting for clinics.